StenoCare says France submits medical cannabis reimbursement decree for top court review

PUBT · 2d ago
StenoCare says France submits medical cannabis reimbursement decree for top court review
  • StenoCare said France has submitted a draft decree on medical cannabis evaluation, pricing, and reimbursement to the Conseil d’État on July 2, 2026.
  • Management framed the move as a key step toward a permanent French medical cannabis framework, with reimbursement seen as critical for market viability.
  • The company said submission is not final approval; the decree still needs legal review, formal adoption, and publication before applications can open.
  • StenoCare reiterated its ASTRUM 10-10 oil is positioned for the planned framework, with product approvals expected to require French-specific dossiers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. StenoCare A/S published the original content used to generate this news brief via Cision (Ref. ID: 202608070200BITN____UKPR__EN_20260806-BIT-5142-0) on August 07, 2026, and is solely responsible for the information contained therein.